Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.006 AUD | 0.00% | -25.00% | -45.45% |
18/04 | Bioxyne to Raise AU$1.45 Million via Share Issuance | MT |
29/02 | Bioxyne Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 2.48M 1.62M 135M | Sales 2023 | 5.3M 3.46M 289M | Capitalization | 38.03M 24.84M 2.07B |
---|---|---|---|---|---|
Net income 2022 | - 0 0 | Net income 2023 | -1M -653K -54.46M | EV / Sales 2022 | 2.22 x |
Net cash position 2022 | 2.17M 1.42M 118M | Net cash position 2023 | 3.29M 2.15M 179M | EV / Sales 2023 | 6.55 x |
P/E ratio 2022 |
-30.1
x | P/E ratio 2023 |
-13.9
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 22.01% |
1 week | -25.00% | ||
Current month | -50.00% | ||
1 month | -45.45% | ||
3 months | -53.85% | ||
6 months | -50.00% | ||
Current year | -45.45% |
Managers | Title | Age | Since |
---|---|---|---|
Sam Watson
CEO | Chief Executive Officer | - | 19/23/19 |
Rachel Qian
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Peng Ho
CHM | Chairman | 65 | 30/12/30 |
Jason Hine
BRD | Director/Board Member | - | 19/23/19 |
Sam Watson
CEO | Chief Executive Officer | - | 19/23/19 |
Date | Price | Change | Volume |
---|---|---|---|
01/24/01 | 0.006 | 0.00% | 266,100 |
30/24/30 | 0.006 | -25.00% | 15,475,010 |
29/24/29 | 0.008 | 0.00% | 80,000 |
26/24/26 | 0.008 | +14.29% | 313,973 |
24/24/24 | 0.007 | -12.50% | 241,830 |
Delayed Quote Australian S.E., May 01, 2024 at 11:01 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-45.45% | 7.97M | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- BXN Stock